Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen

Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Real-time RT-PCR is the most commonly used method for COVID-19 diagnosis. However, serological assays are urgently needed as complementary tools to RT-PCR. Hachim et al. 2020 a...

Full description

Bibliographic Details
Main Authors: Pierre Nsele Mutantu, Mya Myat Ngwe Tun, Takeshi Nabeshima, Fuxun Yu, Patrick Kakoni Mukadi, Takeshi Tanaka, Masato Tashiro, Ayumi Fujita, Nobuhiro Kanie, Ryosaku Oshiro, Takahiro Takazono, Yoshifumi Imamura, Tatsuro Hirayama, Meng Ling Moi, Shingo Inoue, Koichi Izumikawa, Jiro Yasuda, Kouichi Morita
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Environmental Research and Public Health
Subjects:
SARS-CoV-2
nucleocapsid protein
IgG indirect ELISA
plaque reduction neutralization test
Online Access:https://www.mdpi.com/1660-4601/18/18/9630

Internet

https://www.mdpi.com/1660-4601/18/18/9630

Similar Items